Yixiang Zhan Weipeng Zhao Kemin Ni Zhaoce Liu Yanjun Su Xichuan Li Heng Zhang Chunze Zhang
10.3389/fimmu.2022.1025125
Front Immunol
2022 Nov 23;13:1025125.
camrelizumab case report central retinal vein occlusion immunotherapy lung cancer vitreous hemorrhage
CC BY
https://pubmed.ncbi.nlm.nih.gov/36505454/
Melanoma / drug therapy Retinal Vein Occlusion / diagnosis Retinal Vein Occlusion / drug therapy
Melanoma / drug therapy Retinal Vein Occlusion / diagnosis Retinal Vein Occlusion / drug therapy Case Reports Eye Humans Immunotherapy Male Middle Aged Vitreous Hemorrhage
PMC9726748
36505454
Case report: Camrelizumab associated with central retinal vein occlusion
2022